Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Early research (Phase 1)Study completedNCT01473095What this trial is testingPhase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant LymphomaWho this might be right forSolid TumorMalignant LymphomaTumor ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 120
Early research (Phase 1)Ended earlyNCT04800822What this trial is testingPF-07284892 in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Pfizer 53
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT01799083What this trial is testingLower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell LymphomasWho this might be right forSolid TumorsB Cell Lymphoma Han weidong 100
Testing effectiveness (Phase 2)Study completedNCT02643303What this trial is testingTremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible CancersWho this might be right forHead and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more Ludwig Institute for Cancer Research 58
Not applicableLooking for participantsNCT04510766What this trial is testingTumor Molecular Profiling in Early Phase Clinical TrialsWho this might be right forAdvanced Solid TumorLymphoma Oncology Institute of Southern Switzerland 40
Early research (Phase 1)UnknownNCT03692520What this trial is testingSafety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Sinocelltech Ltd. 90
Early research (Phase 1)Study completedNCT01065025What this trial is testingOpen Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced MalignanciesWho this might be right forAdvanced and Incurable Solid TumorsMalignant Lymphomas 4SC AG 60
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Early research (Phase 1)Study completedNCT03763149What this trial is testingA Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and LymphomasWho this might be right forAdvanced Malignancies Innovent Biologics (Suzhou) Co. Ltd. 20
Early research (Phase 1)Ended earlyNCT01209832What this trial is testingA Tasisulam and Midazolam Drug Interaction Study in Cancer PatientsWho this might be right forAdvanced Cancer Eli Lilly and Company 11
Early research (Phase 1)Active Not RecruitingNCT02321501What this trial is testingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerWho this might be right forALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390839What this trial is testingTesting Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+1 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Active Not RecruitingNCT05490771What this trial is testingTesting Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm+3 more National Cancer Institute (NCI) 35
Not applicableActive Not RecruitingNCT04090619What this trial is testingFrequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary CaregiversWho this might be right forAdvanced Malignant Solid NeoplasmCaregiverMetastatic Malignant Solid Neoplasm+4 more M.D. Anderson Cancer Center 192
Early research (Phase 1)Study completedNCT00293345What this trial is testing3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06357975What this trial is testingTesting Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 44
Early research (Phase 1)WithdrawnNCT03422874What this trial is testingDose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forNeoplasmsLymphoma Dartmouth-Hitchcock Medical Center